Representative Single Agents Chemotherapy Regimens for MBC 2007 NCCN Recommendations Doxorubicin Epirubicin Pegylated liposomal doxorubicin Paclitaxel
{"Image DocumentName": "Chemotherapy Regimens for MBC 2007 NCCN Recommendations", "Image ImageDescription": "Representative Single Agents. Combination Regimens. Doxorubicin. Epirubicin. Pegylated liposomal doxorubicin. Paclitaxel. Docetaxel. Capecitabine. Vinorelbine. Gemcitabine. Albumin-bound paclitaxel. CAF/FAC (cyclophosphamide/doxorubicin/ fluorouracil) FEC (fluorouracil/epirubicin/cyclophosphamide) AC (doxorubicin/cyclophosphamide) EC (epirubicin/cyclophosphamide) AT (doxorubicin/docetaxel; doxorubicin/paclitaxel) CMF (cyclophosphamide/methotrexate/fluorouracil) Docetaxel/capecitabine. GT (gemcitabine/paclitaxel) F = fluorouracil; A = doxorubicin; C = cyclophosphamide; E = epirubicin; T = paclitaxel; M = methotrexate. National Comprehensive Cancer Network. Breast Cancer. Clinical Practice Guidelines in Oncology \u2013 v National Comprehensive Cancer Network. Breast Cancer. Clinical Practice Guidelines in Oncology \u2013 v", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}